It’s been a slow start for CVs.
The company is struggling to find its footing in the US after losing millions in the 2008 financial crisis.
But there’s no shortage of interest in the CVS brand.
As the US market continues to recover, CVS is looking to expand into the UK, where it’s seen an explosion in demand for its care products, especially for cancer patients.
CVS Healthcare will invest more than $4bn over the next two years to expand in the UK and Ireland, with plans to open the first of its two new CVS hospitals in Birmingham, the BBC reported.
The investment is aimed at bringing the CNV brand to the UK in the near future, and will include a new brand, CNV Health, which will be used to identify, promote and provide high-quality healthcare services in the NHS.
The new CNV health plan will be rolled out to hospitals across the UK.
In the UK alone, there are currently more than 6.7 million people who have CNV, the BBC reported, but only around 4,000 of those patients receive the high-tech treatment.
According to the BBC, CNV Health has been a key focus for the company.
Its main focus is on identifying high-risk populations, which it says includes patients who have cancer, heart disease and other diseases that are common in the developed world.
“This strategy is the result of years of investment in the development of a range of new, highly innovative and high-value health products and services,” the company said in a statement.
Since its launch in the United States in 2011, CVD has been on the rise, with more than half of US adults living with the disease.
While the CVD market is booming, CVA has struggled to find any traction in the country.
Even though CVS has invested billions in the brand, it’s only managed to grow its share of the US healthcare market by less than 1%.
As of March, healthcare spending was still below what it was in 2015, which is why the company has been focused on the UK market.
“CVS is well positioned to be a leader in the new global health care landscape,” CVA CEO Michael Pachter told the BBC.
“This investment will help us grow our UK health network in ways that will benefit patients, providers and communities.”
Despite the slow start, CVC said that it expects its UK business to grow to around 10% by 2020.
Despite CVS’s struggles, it is still optimistic about its future in the world’s biggest health care market.
“The next big wave of innovation in health care will be driven by the rise of CVS Health, as well as the UK’s growing role as the leader in patient and provider engagement in healthcare delivery,” Pachters said.
What’s your favourite brand?
Let us know in the comments below!